Latest filing published 25 Aug 2025 for CERENOME, INC., €46k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -76.3%Entry US$12.75 · Close at T+365 US$3.02
- -86.9%Entry US$55.25 · Close at T+365 US$7.25
- -37.4%Entry US$47.50 · Close at T+365 US$29.75
- -46.3%Entry US$54.50 · Close at T+365 US$29.25
- -22.5%Entry US$42.25 · Close at T+365 US$32.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert P. Lenk: trading record in brief
Robert P. Lenk, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cerenome, Inc. and Luna Innovations Inc. The record holds 15 filings, for trades running from 7 March 2008 to 22 August 2025.
In open-market terms, that means 12 purchases worth €108k on one side and 1 sale worth €443 on the other. The net balance comes to €108k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants. 2025 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €6,273. 2 out of 12 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 12 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 50% of cases, with a median move of -2.9%. These figures describe past trades and do not predict future prices.
On 25 August 2025 came the latest disclosure, an open-market purchase for €46k in Cerenome, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert P. Lenk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 110,000 shares@ US$0.488958.1% of flowCommon StockSEC:0000950170-25-111092:0Canonical exit: 20 Nov 2025 (T+90)
- 4,167 shares@ US$2.049.9% of flowCommon StockSEC:0000950170-24-057451:0Canonical exit: 6 Aug 2024 (T+90)
- 1,000 shares@ US$1.951.7% of flowCommon StockSEC:0001209191-23-055638:1Canonical exit: 14 Feb 2024 (T+90)
- 1,000 shares@ US$1.772.0% of flowCommon StockSEC:0001209191-23-055638:0Canonical exit: 13 Feb 2024 (T+90)
- 4,000 shares@ US$1.434.9% of flowCommon StockSEC:0001209191-23-055264:1Canonical exit: 11 Feb 2024 (T+90)
- 2,000 shares@ US$1.453.4% of flowCommon StockSEC:0001209191-23-055264:0Canonical exit: 8 Feb 2024 (T+90)
- 4,199 shares@ US$1.595.7% of flowCommon StockSEC:0001209191-23-054914:1Canonical exit: 7 Feb 2024 (T+90)
- 5,000 shares@ US$1.659.7% of flowCommon StockSEC:0001209191-23-054914:0Canonical exit: 6 Feb 2024 (T+90)
- 6,000 shares@ US$1.648.5% of flowCommon StockSEC:0001209191-23-054650:1Canonical exit: 5 Feb 2024 (T+90)
- 1,395 shares@ US$1.502.4% of flowCommon StockSEC:0001209191-23-054650:0Canonical exit: 4 Feb 2024 (T+90)
- 1,500 shares@ US$0.31470.6% of flowCommon StockSEC:0001209191-23-001447:0
- 7,000 shares@ US$1.858713.8% of flowCommon StockSEC:0001209191-21-056096:0Canonical exit: 12 Dec 2021 (T+90)
- 3,000 shares@ US$2.497.3% of flowCommon StockSEC:0001209191-20-048319:0Canonical exit: 23 Nov 2020 (T+90)
- 4,916 shares@ US$5.16Common StockSEC:0001181431-08-017947:0
14 of 14 declarations
